Biomimetic
Dental Science

vVARDIS combines breakthrough patented biomimetic dental technologies and cutting-edge science with the legacy of Swiss purity and precision.

vVARDIS Professional
Curodont^TM Products

vVARDIS Professional offers oral care solutions with the patented, clinically-proven biomimetic peptide-based technology. The Curodont^TM product line developed for dental professionals enables the effective treatment and management of diverse indications and conditions, primarily caries, erosion, and sensitivity.

CURODONT^TM REPAIR

Professional treatment to arrest and reverse initial caries through Guided Enamel Regeneration

CURODONT^TM PROTECT

Professional gel for caries prophylaxis and protection from erosion

“The day is surely coming when
we will be engaged in practicing preventive
rather than reparative dentistry”

Dr. Greene Vardiman Black - 1896
Father of Operative Dentistry

“The day is surely coming when we will be engaged in practicing preventive rather than reparative dentistry”

Dr. Greene Vardiman Black - 1896
Father of Operative Dentistry

Nature as a model

Enamel is formed by the structured organization of hydroxyapatite crystals over a protein matrix. Once odontogenesis is complete, the natural enamel matrix is permanently degraded, and as a result, enamel cannot regrow or repair itself naturally. Backed by over 20 years of research and more than 200 studies, the vVARDIS technologies are based on a simple peptide that mimics the natural enamel matrix to regenerate enamel.

A disruptive technology

The peptide, made of naturally occuring aminoacids and with a high affinity to hydroxyapatite, can self-assemble into a biomimetic matrix using calcium and phosphate ions from the saliva. This matrix regenerates enamel until the depth of early carious lesions and on the tooth surface.

The peptide-based technology is incredibly versatile: it can be easily adapted into various formulations that can treat and manage early caries and sensitivity, protect from caries and erosion, and deliver a gentle teeth whitening.

Testimonials

“CURODONT™ REPAIR allows you to regenerate enamel in ways that we haven’t seen before in clinical practice. It allows us to treat patients minimally-invasively, pain-free, injection-free and is going to change the face of dentistry.”

“Where previously we would ‘watch and wait’, we can actually now treat minimally-invasively with amazing results.”

«Ultimately, The CURODONT^TM REPAIR technology is a Guided Enamel Regeneration (GER). You apply CURODONT^TM REPAIR and give nature time to regenerate.»

«CURODONT^TM REPAIR is the classic practice builder. It motivates my patients to keep to the specified recall appointments.»

"Instead of waiting and letting it progress, we arrest the cavity at an early stage so we can heal the tooth before it turns into decay.”

Dr. Jin J. Vaghela & Dr. Kish Patel

Dr. Farzeela Rupani, Colosseum Group

Dr. Torsten Seidenstricker

Dr. Giovanni Sammarco

Dr. Lucia Lisi

Dr. Federico Emiliani

Prof. Jablonski-Momeni

Dr. Federico Emiliani

Curodont^TM for Dental Practitioners

A Treatment for Every Smile

The Future of Oral Health is Here

Interview with Dr Brian Novy

For patients at home vVARDIS Daily Oral Care

Originally developed for dental professionals, the vVARDIS technologies are also infused in the vVARDIS oral care line for daily use at home. Enriched with hydroxyapatite, this distinctive line uniquely creates an mineral-rich layer on the enamel surface that helps repair, protect and strengthen the enamel while providing a natural whitening effect. Sustainably produced in Switzerland.

About Us

Founded in Switzerland by Dr. Haley and Dr. Goly Abivardi, vVARDIS offers breakthrough biomimetic, non-invasive, dental products to treat early-stage decay and for enamel remineralization.

vVARDIS is the result of a combined 30 years of dental and entrepreneurial experience, and 20 years of laboratory and clinical research, paired with the commitment of its founders to make an impact on people’s lives.

Latest News

vVARDIS Secures $50 Million
in New Funding

– Totalling $85 Million in Financing from Global Healthcare Investor OrbiMed –
to Expand Rollout of Curodont™, Its Drill-Free Early Tooth Decay Treatment

READ THE FULL PRESS RELEASE

NEW WEBINAR

Regenerate, don’t restore: how to adopt the next-gen caries treatment with peptides and saliva insight

GO TO WEBINAR PAGE

vVARDIS e-Learning Platform is now available

to help you master Curodont Repair

View Courses

vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay

Biomimetic
Dental Science